Thank you for subscribing!
Finfeed Archived Feb 12, 2021
As Australia prepares to roll out its first COVID-19 vaccine, (and the citizens of Melbourne enter lockdown 4.0) it’s worth looking at the impact the roll-out will have on its maker – AstraZeneca.
Finfeed Archived Feb 02, 2021
The FTSE 100 is enjoying a buoyant start to the week, with precious metal miners and high-street names leading the charge. However, fears remain thanks to weak Chinese PMI data, and questions around US stimulus efforts.
Finfeed Archived Nov 26, 2020
Energy stocks are rising against the global equity market, extending the massive rally since 8 November when Pfizer announced its COVID-19 vaccine.
Finfeed Archived Nov 25, 2020
Big news for Tesla is having an impact on that company. Tesla boss Elon Musk plans to build the world's largest battery-cell factory at the group's electric car plant near Berlin. It will be the first in Europe and is expected to churn out 500,000 Model 3 sedans and Model Y SUVs per year.
Get expert stock analysis direct in your inbox
Finfeed Archived Nov 24, 2020
“Another Monday vaccine announcement has brought a more mixed report from AstraZeneca, with the UK-led project bringing vastly different results depending on the dosing method."
Finfeed Archived Nov 20, 2020
“In the last few days, there’s been a historical, violent rotation from growth and momentum stocks, like stay-at-home tech, to value funds, including financials and industrials, as a result of the positive vaccine news."
“Virus fears hit an overextended global stock market, knocking European equities sharply lower and pointing towards a weaker start in the US.”
Finfeed Archived Nov 13, 2020
The accelerated uptake of technology and online activities, including healthcare services, has created a step-change in the way people conduct their daily lives. Many healthcare stocks are thriving because of it.
“European markets were in the red, coming off their highs as infection rates continue to rise and the realisation that a vaccine is not an overnight fix dawns on investors.”
Finfeed Archived Nov 10, 2020
The announcement that Pfizer and BioNTech’s COVID-19 vaccine was 90% effective in tests saw global markets soar overnight.
Join Our Mailing List
